Growth Metrics

Baxter International (BAX) Cost of Revenue (2016 - 2024)

Historic Cost of Revenue for Baxter International (BAX) over the last 16 years, with Q4 2024 value amounting to $1.8 billion.

  • Baxter International's Cost of Revenue rose 24765.43% to $1.8 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $7.3 billion, marking a year-over-year increase of 1800.32%. This contributed to the annual value of $6.7 billion for FY2024, which is 711.76% up from last year.
  • Latest data reveals that Baxter International reported Cost of Revenue of $1.8 billion as of Q4 2024, which was up 24765.43% from $1.7 billion recorded in Q3 2024.
  • In the past 5 years, Baxter International's Cost of Revenue registered a high of $2.6 billion during Q2 2023, and its lowest value of -$1.2 billion during Q4 2023.
  • Its 5-year average for Cost of Revenue is $1.7 billion, with a median of $1.9 billion in 2021.
  • Per our database at Business Quant, Baxter International's Cost of Revenue plummeted by 13099.73% in 2022 and then skyrocketed by 24765.43% in 2024.
  • Over the past 5 years, Baxter International's Cost of Revenue (Quarter) stood at $2.0 billion in 2020, then dropped by 6.78% to $1.9 billion in 2021, then tumbled by 131.0% to -$575.0 million in 2022, then plummeted by 111.3% to -$1.2 billion in 2023, then surged by 247.65% to $1.8 billion in 2024.
  • Its Cost of Revenue was $1.8 billion in Q4 2024, compared to $1.7 billion in Q3 2024 and $1.7 billion in Q2 2024.